All content for CRISPR Cuts is the property of Synthego and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to the CRISPR revolution. Take a break and join us as we guide conversations with an expert CRISPR cast about this cutting-edge science.
Imran House and Junyun Lai Discuss CRISPR Screening in Immuno-Oncology
CRISPR Cuts
26 minutes 6 seconds
1 year ago
Imran House and Junyun Lai Discuss CRISPR Screening in Immuno-Oncology
Imran House, Ph.D. and Junyun Lai Ph.D. are Senior Scientists at the biotech start-up, oNKo-Innate in Melbourne, Australia that focuses on developing immuno-oncology therapies. In this episode, they discussed what they do at oNKo-innate, their career transitions from leaving academics to entering the biotech industry, and how CRISPR is impacting cancer-immunotherapy development. They also discussed overcoming common obstacles faced when developing cytokine therapies and future outlooks on clinical trials using these kinds of therapies.
Reach out and connect with both Imran and Junyun on social media platforms:
Imran House, Ph.D.
LinkedIn
X: @ImranHouse
Junyun Lai, Ph.D.
LinkedIn
X: @JunyunLai
CRISPR Cuts
Welcome to the CRISPR revolution. Take a break and join us as we guide conversations with an expert CRISPR cast about this cutting-edge science.
